CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

EarningsNegative
AI Analysis

Summary

Vivos Therapeutics reported Q2 earnings with a net loss and revenue that fell short of estimates. The company's financial performance lagged expectations in the second quarter.

Importance:3/10
Sentiment:
-0.60
earningsq2_resultsrevenue_missnet_loss
Related Companies

Read the original article

Published by yahoo_finance on August 14, 2026 9:40 PM

Read Original